---
figid: PMC2360507__95-6603316f1
figlink: /pmc/articles/PMC2360507/figure/fig1/
number: F1
caption: 'A model for endocrine resistance and its treatment: crosstalk between growth-factor
  receptor and ER pathways. Increased growth factor signaling may contribute to endocrine
  resistance by directly activating ER and leading to the transcription of oestrogen-related
  genes. Novel therapies can target a number of steps along this dysregulated signaling
  pathway and may therefore have an important role in the treatment of endocrine resistant
  breast cancer.'
pmcid: PMC2360507
papertitle: 'Combination therapy with aromatase inhibitors: the next era of breast
  cancer treatment?.'
reftext: A Leary, et al. Br J Cancer. 2006 Sep 18;95(6):661-666.
pmc_ranked_result_index: '16105'
pathway_score: 0.9642548
filename: 95-6603316f1.jpg
figtitle: 'Endocrine resistance and its treatment: crosstalk between growth-factor
  receptor and ER pathways'
year: '2006'
organisms: Homo sapiens
ndex: 78bedac2-deb2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2360507__95-6603316f1.html
  '@type': Dataset
  description: 'A model for endocrine resistance and its treatment: crosstalk between
    growth-factor receptor and ER pathways. Increased growth factor signaling may
    contribute to endocrine resistance by directly activating ER and leading to the
    transcription of oestrogen-related genes. Novel therapies can target a number
    of steps along this dysregulated signaling pathway and may therefore have an important
    role in the treatment of endocrine resistant breast cancer.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - PIK3R4
  - RAF1
  - BRAF
  - KRAS
  - MAPK1
  - PIK3R5
  - MAPK14
  - PIK3CD
  - PIK3R6
  - AKT1
  - ARAF
  - MAP2K2
  - MAPK10
  - PIK3CG
  - MAPK12
  - ERBB2
  - AKT3
  - MAPK9
  - MTOR
  - PIK3R3
  - MAP2K1
  - AKT2
  - NRAS
  - MAPK13
  - PIK3CB
  - MAPK11
  - IGF1R
  - MAPK3
  - MAPK8
  - PIK3CA
  - EGFR
  - Temsirolimus
  - Tipifarnib
  - estrogen
  - Ser
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: IGFIR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Tipifarnib
  source: MESH
  identifier: C402769
- word: estrogen
  source: MESH
  identifier: D004967
- word: Ser
  source: MESH
  identifier: D012694
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2360507__F1
redirect_from: /figures/PMC2360507__F1
figtype: Figure
---
